| Dr Lila Mojdeh Bahadori, MD | |
|
10301 Georgia Avenue, Suite 304, Silver Spring, MD 20902 | |
| (301) 681-7200 | |
| (301) 681-5968 |
| Full Name | Dr Lila Mojdeh Bahadori |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 10301 Georgia Avenue, Silver Spring, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235228354 | NPI | - | NPPES |
| 260990800 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | D0047928 (Maryland) | Primary |
| Entity Name | Gaithersburg Critical Care Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144250218 PECOS PAC ID: 1658260435 Enrollment ID: O20040311000226 |
News Archive
Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of autoimmune and gastrointestinal diseases, today announced that the United States Patent and Trademark Office has issued four key patents: 7,943,312; 7,928,056; 7,923,532; and 7,910,541, protecting various aspects of Alvine's core technology.
Transave, Inc., today reported positive results from a Phase II clinical trial in non-cystic fibrosis (CF) bronchiectasis patients for its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation). The Phase II data indicated that ARIKACE, delivered once daily for 28 consecutive days, demonstrated superior clinical benefit compared to placebo as measured by patient and physician reported outcomes and reduction in Pseudomonas aeruginosa density.
This remarkable publication focuses on the importance of genetics in mental retardation, investigating the extent to which molecular diagnostic capability and the understanding of genetic causes have improved over recent years. As a result, clinical evaluation and diagnostic laboratory practice are now undergoing an unprecedented period of change.
A new study exposes the risk of nutritional deficiencies in severely obese teens - both those who had weight loss surgery and those who did not.
Six Ontario Researchers have received funding of $500,000 OR $1 million to further cancer research over the next five years, Cancer Care Ontario's Research Program announced today.
› Verified 1 days ago
| Entity Name | Sunrise Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336195734 PECOS PAC ID: 2860488095 Enrollment ID: O20040422001551 |
News Archive
Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of autoimmune and gastrointestinal diseases, today announced that the United States Patent and Trademark Office has issued four key patents: 7,943,312; 7,928,056; 7,923,532; and 7,910,541, protecting various aspects of Alvine's core technology.
Transave, Inc., today reported positive results from a Phase II clinical trial in non-cystic fibrosis (CF) bronchiectasis patients for its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation). The Phase II data indicated that ARIKACE, delivered once daily for 28 consecutive days, demonstrated superior clinical benefit compared to placebo as measured by patient and physician reported outcomes and reduction in Pseudomonas aeruginosa density.
This remarkable publication focuses on the importance of genetics in mental retardation, investigating the extent to which molecular diagnostic capability and the understanding of genetic causes have improved over recent years. As a result, clinical evaluation and diagnostic laboratory practice are now undergoing an unprecedented period of change.
A new study exposes the risk of nutritional deficiencies in severely obese teens - both those who had weight loss surgery and those who did not.
Six Ontario Researchers have received funding of $500,000 OR $1 million to further cancer research over the next five years, Cancer Care Ontario's Research Program announced today.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lila Mojdeh Bahadori, MD 8229 Osage Lane, Bethesda, MD 20817 Ph: (301) 263-0068 | Dr Lila Mojdeh Bahadori, MD 10301 Georgia Avenue, Suite 304, Silver Spring, MD 20902 Ph: (301) 681-7200 |
News Archive
Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of autoimmune and gastrointestinal diseases, today announced that the United States Patent and Trademark Office has issued four key patents: 7,943,312; 7,928,056; 7,923,532; and 7,910,541, protecting various aspects of Alvine's core technology.
Transave, Inc., today reported positive results from a Phase II clinical trial in non-cystic fibrosis (CF) bronchiectasis patients for its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation). The Phase II data indicated that ARIKACE, delivered once daily for 28 consecutive days, demonstrated superior clinical benefit compared to placebo as measured by patient and physician reported outcomes and reduction in Pseudomonas aeruginosa density.
This remarkable publication focuses on the importance of genetics in mental retardation, investigating the extent to which molecular diagnostic capability and the understanding of genetic causes have improved over recent years. As a result, clinical evaluation and diagnostic laboratory practice are now undergoing an unprecedented period of change.
A new study exposes the risk of nutritional deficiencies in severely obese teens - both those who had weight loss surgery and those who did not.
Six Ontario Researchers have received funding of $500,000 OR $1 million to further cancer research over the next five years, Cancer Care Ontario's Research Program announced today.
› Verified 1 days ago
Jyotsna Mareedu, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1500 Forest Glen Rd, Silver Spring, MD 20910 Phone: 301-754-7000 | |
Sean S Saedi, M. D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12210 Plum Orchard Drive, Suite 212, Silver Spring, MD 20904 Phone: 301-593-6844 Fax: 301-593-3832 | |
Herman B Segal, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 8630 Fenton St Ste 1105, Silver Spring, MD 20910 Phone: 301-681-9095 Fax: 410-367-2114 | |
Dr. Rajeev Batra, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 11120 New Hampshire Ave Ste 300, Silver Spring, MD 20904 Phone: 301-593-9612 Fax: 301-593-6290 | |
Anuradha A Arun, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9801 Georgia Ave, Suite 224, Silver Spring, MD 20902 Phone: 301-593-9800 Fax: 301-593-1061 | |
Dr. Seife Yohannes, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1215 E West Hwy, #910, Silver Spring, MD 20910 Phone: 301-273-3068 | |
Patricia Keegan, Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 10903 New Hampshire Ave, Building 22, Room 2328, Silver Spring, MD 20903 Phone: 301-796-1387 |